- Faculty
- Full-time Faculty
- George Arana, M.D.
- William Bernet, M.D.
- Jennifer U. Blackford, Ph.D.
- William Bobo, M.D.
- George C. Bolian, M.D.
- Kimberly Brown, Ph.D.
- Michael Bubser, Ph.D.
- Courtney Burnette, PhD
- Carissa Cascio, Ph.D.
- Thomas Catron, Ph.D.
- Nathaniel Clark, M.D.
- Ronald L. Cowan, M.D., Ph.D.
- Michael Cull, MSN
- Bruce Davis, Ph.D.
- Ariel Y. Deutch, Ph.D.
- Richard Epstein, Ph.D.
- Elliot M. Fielstein, Ph.D.
- A. J. Reid Finlayson, M.D.
- P. Tobi Fishel, Ph.D.
- Jeri Fitzpatrick, M.D.
- Erin Fowler, Ph.D.
- Michael Franklin, M.D.
- D. Catherine Fuchs, M.D.
- Lawrence S. Gaines, Ph.D.
- Virginia Gardner, M.S.N.
- Harry E. Gwirtsman, M.D.
- Kirsten L. Haman, Ph.D.
- Helen Hatfield, M.S.N.
- Brian D. Haworth, Psy.D.
- Stephan Heckers, M.D., M.Sc.
- Willam A. Hewlett, M.D., Ph.D.
- Mei Huang, Ph.D.
- Tarah M. Kuhn, Ph.D.
- Joseph D. LaBarbera, Ph.D.
- Thomas J. Lavie, M.D.
- Myung Lee, M.D.
- Zhu Li, Ph.D.
- Donald Manier, MA
- Ginger T. Manley, MSN, APRN
- Peter R. Martin, M.D.
- Lynne L. McFarland, M.S.N.
- Elise McMillan, JD
- Herbert Meltzer, M.D.
- Karoly Mirnics, M.D.
- Stephen A. Montgomery, M.D.
- Michael J. Murphy, M.D., M.P.H.
- J. Richard Navarre, MD
- Diana Neely, Ph.D.
- Amy Nicholson, MA, LPE
- Jo Cara Pendergrass, Ph.D.
- Paul W. Ragan, M.D.
- Howard B. Roback, Ph.D.
- Scott Rodgers, M.D.
- Ronald Salomon, M.D.
- Dennis Schmidt, Ph.D.
- Jennifer A. Scroggie, MSN
- Sandra Seidel, MSN
- Sam R. Sells, M.D.
- Richard C. Shelton, M.D.
- Michael H. Sherman, M.D.
- Karen L. Starr, MSN
- Jeffrey G. Stovall, M.D.
- David Street, M.D.
- Michael G. Tramontana, Ph.D.
- Patti van Eys, PhD
- Jeremy Veenstra-VanderWeele, M.D.
- James S. Walker, Ph.D.
- Huidong Wang, Ph.D.
- Zachary Warren, Ph.D.
- David D. Weinstein, M.D.
- Amanda Wilson, MD
- Part-time Faculty
- Full-time Faculty
Mood Disorders Research Program
The mission of the Mood Disorders Research Program is to expand our understanding of the causes of depression and bipolar disorder using the best available means of investigation. This is for the purpose of finding better ways of treating these complex conditions and developing early detection and intervention methods to prevent them.
Director: Richard Shelton, M.D.
Assistant: Waverly DeMers (e-mail)
Faculty
Brown, Laurel
Gardner, Virginia
Haman, Kirsten
Manier, Donald (Hal)
Scroggie, Jennifer
Seidel, Sandra
Tucker, Dorothy
Staff
Stephanie Addington
Nathan Ford
Kerry Hook
Margaret Lovett
Tynya Patton
Brian Pollock
Marijean Rue
Dorothy Smith
Emily Sumner
Jeffrey Wilhelm
Projects (Starred ones are recruiting)
1. Double-Blind, Placebo Controlled Study of 6(S)-5-MTHF among SSRI-Resistant Outpatients with Major Depressive Disorder*
2. Orally-Disintegrating vs. Regular Olanzapine Tablets: Effects on Weight and GI Hormones*
3. Signal Transduction in Depression*
4. Monoamine Transporter and Receptor Variants in Major Depression*
5. Prevention of Recurrence in Depression with Drugs and Cognitive Therapy
6. MRI studies of stress and cognitive controls in MDD: Affective Modulation of Attention*
7. MRI studies of stress and cognitive controls in MDD: Reappraisal*
8. Hippocampal Damage and Breast Cancer*
9. Structural Genomics of Norepinephrine Transporters (Psychiatric Effects in Orthostatic Intolerance and Idiopathic Cardiomyopathy)*
Click here for information on current studies.
Director: Richard Shelton, M.D.
Assistant: Waverly DeMers (e-mail)
Faculty
Brown, Laurel
Gardner, Virginia
Haman, Kirsten
Manier, Donald (Hal)
Scroggie, Jennifer
Seidel, Sandra
Tucker, Dorothy
Staff
Stephanie Addington
Nathan Ford
Kerry Hook
Margaret Lovett
Tynya Patton
Brian Pollock
Marijean Rue
Dorothy Smith
Emily Sumner
Jeffrey Wilhelm
Projects (Starred ones are recruiting)
1. Double-Blind, Placebo Controlled Study of 6(S)-5-MTHF among SSRI-Resistant Outpatients with Major Depressive Disorder*
2. Orally-Disintegrating vs. Regular Olanzapine Tablets: Effects on Weight and GI Hormones*
3. Signal Transduction in Depression*
4. Monoamine Transporter and Receptor Variants in Major Depression*
5. Prevention of Recurrence in Depression with Drugs and Cognitive Therapy
6. MRI studies of stress and cognitive controls in MDD: Affective Modulation of Attention*
7. MRI studies of stress and cognitive controls in MDD: Reappraisal*
8. Hippocampal Damage and Breast Cancer*
9. Structural Genomics of Norepinephrine Transporters (Psychiatric Effects in Orthostatic Intolerance and Idiopathic Cardiomyopathy)*
Click here for information on current studies.
